documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

17 rows where docket_id = "FDA-2021-N-0862" and posted_year = 2022 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 2022 · 17 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-N-0862-0177 FDA None FDA-2021-N-0862 FDA Listening Session with APhA Stakeholders--High-Level Notes Other Meeting Exhibits 2022-11-22T05:00:00Z 2022 11 2022-11-22T05:00:00Z 2022-11-26T04:59:59Z 2022-11-22T20:15:53Z   0 0 09000064854fc3fd
FDA-2021-N-0862-0140 FDA None FDA-2021-N-0862 Nonprescription Drug Product With an Additional Condition for Nonprescription Use; Extension of Comment Period Proposed Rule Extension of Comment Period 2022-10-24T04:00:00Z 2022 10 2022-10-24T04:00:00Z   2022-11-22T18:58:05Z 2022-23033 0 0 090000648544cb97
FDA-2021-N-0862-0043 FDA None FDA-2021-N-0862 Request for Extension from Consumer Healthcare Products Association Other Request for Extension 2022-10-06T04:00:00Z 2022 10 2022-10-06T04:00:00Z   2022-11-22T18:57:53Z   0 0 09000064853bd957
FDA-2021-N-0862-0039 FDA None FDA-2021-N-0862 Request for Extension from American Pharmacists Association Other Request for Extension 2022-09-26T04:00:00Z 2022 9 2022-09-26T04:00:00Z   2022-11-22T18:57:40Z   0 0 090000648536e90d
FDA-2021-N-0862-0001 FDA None FDA-2021-N-0862 Nonprescription Drug Product With an Additional Condition for Nonprescription Use Proposed Rule Notice of Proposed Rulemaking (NPRM) 2022-06-28T04:00:00Z 2022 6 2022-06-28T04:00:00Z 2022-11-26T04:59:59Z 2024-08-23T01:00:37Z 2022-13309 0 0 09000064851a6c55
FDA-2021-N-0862-0008 FDA None FDA-2021-N-0862 Reference 6- Engelberg Expert Workshop--Exploring Implications of the Nonprescription Drug Safe Use Regulatory Expansion Initiative on Reimbursement and Access_2013 re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:48:58Z   0 0 09000064851a6e08
FDA-2021-N-0862-0011 FDA None FDA-2021-N-0862 Reference 9 - 70 FR 52050 re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:46:47Z   0 0 09000064851a6e05
FDA-2021-N-0862-0004 FDA None FDA-2021-N-0862 Reference 2- Journal of Research in Pharmacy Practice re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:32:38Z   0 0 09000064851a6e07
FDA-2021-N-0862-0010 FDA None FDA-2021-N-0862 Reference 8- 83 FR 13394 re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:45:35Z   0 0 09000064851a6e03
FDA-2021-N-0862-0009 FDA None FDA-2021-N-0862 Reference 7- FDA Preliminary Regulatory Impact Analysis_Initial Regulatory Flexibility Analysis Unfunded Mandates Reform Act Analysis re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:43:52Z   0 0 09000064851a6e04
FDA-2021-N-0862-0005 FDA None FDA-2021-N-0862 Reference 3- Guidance for Industry Label Comprehension Studies for Nonprescription Drug Products re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:34:10Z   0 0 09000064851a56d6
FDA-2021-N-0862-0007 FDA None FDA-2021-N-0862 Reference 5- Engelberg Expert Workshop--Innovative Technologies and Nonprescription Medications--Addressing Undertreated Diseases and Conditions through Technology Enabled Self-Care re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:39:56Z   0 0 09000064851a6e0a
FDA-2021-N-0862-0003 FDA None FDA-2021-N-0862 Reference 1- Guidance for Industry Self-Selection Studies for Nonprescription Drug Products re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:30:20Z   0 0 09000064851a56d8
FDA-2021-N-0862-0013 FDA None FDA-2021-N-0862 Reference 11 - 83 FR 33938 re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:49:29Z   0 0 09000064851a6e02
FDA-2021-N-0862-0002 FDA None FDA-2021-N-0862 Reference List re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:28:40Z   0 0 09000064851a56d7
FDA-2021-N-0862-0006 FDA None FDA-2021-N-0862 Reference 4- Engleberg Expert Workshop--Nonprescription Medications With Conditions of Safe Use as a Novel Solution for Undertreated Diseases or conditions re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:38:18Z   0 0 09000064851a6e06
FDA-2021-N-0862-0012 FDA None FDA-2021-N-0862 Reference 10 - 77 FR 12059 re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use Supporting & Related Material Background Material 2022-06-28T04:00:00Z 2022 6     2022-06-28T13:49:16Z   0 0 09000064851a6e09

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;